Objectives: Isolated proximal-without-distal (buttock but not calf) exercise-related lower-limb ischemia (IPI) might develop in the presence of arterial lesions impairing the blood flow supply toward the hypogastric vascular bed. In IPI, lower-limb sensory nerve dysfunction might occur from the sacral nerve plexus becoming ischemic during exercise. The purpose of this study was to compare patients with IPI with healthy controls for the presence of sensory nerve dysfunction, as assessed using somatosensory testing (SST).
L ower-extremity peripheral arterial disease (PAD) affects around 20% of individuals aged more than 65 years. 1 Patients with moderate PAD (Fontaine stage II) often experience ischemic leg pain during exercise that is relieved by rest (intermittent claudication). In severe PAD (stages III and IV), ischemic leg pain is also experienced at rest. Thus, PAD is a common cause of leg pain.
The chronic ischemic pain experienced by patients with severe chronic ischemia is thought to be of mixed nociceptive and neuropathic origin. 2, 3 Evidence for the latter in chronically ischemic limbs includes abnormal sensory nerve function, as assessed by electroneurography [4] [5] [6] or quantitative sensory testing (QST), 2, 6 and the presence of lower-limb symptoms such as numbness, weakness, and paresthesia. 6 Furthermore, this sensory nerve dysfunction appears independent of frequently coexisting diabetes. 2 The association between transient exertion-related ischemia and lower-limb sensory nerve dysfunction is unclear. For example, the functioning of the sural nerve, which is a large myelinated sensory nerve in the leg, has been shown to be impaired 7 or normal 8 in patients with moderate PAD. Similarly, the functional integrity of smaller myelinated (eg, A, Ad) and unmyelinated (eg, C) fibers, which can be assessed using QST, 9, 10 has been shown to be generally depressed 2 or normal 3 in nondiabetic patients with intermittent claudication. It is likely that these conflicting findings are largely explained by the differences in methods used and patients tested.
No study has investigated if isolated proximal, exerciserelated lower-limb ischemia (IPI), which is usually caused by narrowing of the internal iliac arteries, is associated with lower-limb sensory nerve dysfunction. An association might exist in this form of chronic exercise-induced ischemia because the blood supply of the sacral nerve plexus, which supplies sensory innervation to the legs (and specifically the posterior thigh, most of the lower leg, the entire foot, and part of the pelvis), 11 derives predominantly from the branches of the internal iliac artery. 12 Indirect evidence also supports the presence of sensory impairment in patients with IPI. For example, patients with internal iliac artery disease 13 or IPI 14 often experience burning, tingling, and numbness during exercise, which are common symptoms of small-fiber neuropathy. 15 Thus, it seems that transient exercise-related ischemia at the proximal level has the potential to cause sensory nerve dysfunction, especially in small fibers, in the affected limb(s). The purpose of this study was to test the hypothesis that patients with IPI have lower-limb sensory nerve dysfunction compared with healthy controls, as assessed using somatosensory testing (SST).
MATERIALS AND METHODS

Participants
Patients referred to our laboratory for chronic proximal exercise-induced claudication are routinely investigated with transcutaneous oxygen pressure (TcpO 2 ) recordings. Patients were eligible for the study if the TcpO 2 test confirmed the presence of IPI as detailed below. Exclusion criteria were diabetes mellitus, known or suspected neurological disease, any disease that may induce neuropathy (AIDS, autoimmune disease, etc.), history or treatment for cancer or tuberculosis, chronic substance abuse, use of pain medication, inability to perform treadmill walking exercise, any evidence or past history of lumbar spine stenosis, cancer or radicular compression, and any vascular or nonvascular surgical intervention or arterial angioplasty on the leg investigated. Seventeen patients fulfilling the inclusion and exclusion criteria were finally recruited.
Seventeen age-matched and sex-matched healthy controls were recruited. Control participants were included if they had no signs of PAD (no claudication and normal ankle-brachial pressure index >0.90), and r2 risk factors for PAD (arterial hypertension, hypercholesterolemia, and smoking). Exclusion criteria were the same as for the IPI patients.
This study was approved by the local ethics committee and conducted according to the principles of the Declaration of Helsinki. Written, informed consent was obtained before participants entered the study. The study is accessible through the clinicaltrials.gov website under reference: NCT00152737.
Diagnosis of Isolated Proximal, Exercise-related Lower-limb Ischemia (IPI)
All participants undertook a treadmill-walking exercise test, during which TcpO 2 recordings were made to allow identification of IPI. This valid and reproducible diagnostic technique has been described extensively elsewhere. [16] [17] [18] [19] All exercise tests were performed in a temperaturecontrolled room (21 ± 21C) after an acclimatization period of Z20 minutes. The treadmill test was performed using a 10% slope and a change in speed according to the following procedure. The speed was started at 1 km/h and increased by 0.5 km/h every minute up to 2.5 km/h. After 1 minute at this rate, the treadmill speed was stabilized at 3.2 km/h for an additional 16 minutes. Patients were asked to exercise until the pain became intolerable. At this point, the treadmill was stopped and the maximum walking distance recorded. In normal participants, or in the absence of limiting claudication in patients, the treadmill was stopped after a total walking duration of 20 minutes. A 12-lead electrocardiogram was used to measure heart rate and to detect any arrhythmias or abnormal depolarization events during the exercise procedure.
TcpO 2 data were collected from probes positioned on the chest and both calves and buttocks (TINA-TCM400, Radiometer, Copenhagen DMK). Preparation of the skin and calibration of the TcpO 2 probes was performed as previously described. 16 Before testing, the probes were heated to 44.51C for at least 15 minutes (with the participant standing still) to allow stable resting values to be obtained (defined as TcpO 2 changes <2 mm Hg within 5 min). TcpO 2 data were then recorded at 2-second intervals during a 2-minute resting baseline period, throughout the walking test, and for at least 10 minutes in the standing position after the end of the exercise test.
From the start of the exercise test, we calculated the delta from rest of oxygen pressure (DROP) index for each of the 4 lower-limb sites. 16, 17 This index was calculated as the absolute change in TcpO 2 from rest at the lower-limb level corrected with the absolute change in TcpO 2 from rest at the chest level (chest changes being subtracted if increased from rest or added if decreased from rest). A minimum DROP value during exercise of less than negative 15 mm Hg provides B85% accuracy for the detection of angiographically significant lesions at both the proximal 16 and distal 17 levels. Therefore, the presence of IPI was defined as a DROP value less than negative 15 mm Hg at one or both buttocks and greater than negative 15 mm Hg at both calves. Patients with DROP = 15 mm Hg were excluded to avoid misclassification. In the case of bilateral IPI, we used the leg with the lowest DROP value at the buttock level. Analyses of TcpO 2 recordings were performed blinded to the results of the SST tests.
Assessment of Sensory Nerve Function Through SST
Sensory nerve function was assessed in all participants using a range of thermal, mechanical, and vibration perception tests. These somatosensory tests were performed under identical conditions for each participant and included the use of standardized instructions. Participants were tested while in a comfortable position in a quiet room. They were not given any visual or auditory clues to indicate the start of each stimulus. For patients, the dorsolateral skin of the foot on the most affected side (sensory region of the sural nerve/S1) was tested first, followed by the skin of the right hand (sensory region of the radial nerve/C6-8). Measurements were similarly taken from the healthy controls using the right-hand side of the body. The testing procedure started with the determination of thermal thresholds followed by mechanical thresholds.
Thermal Testing
The tests for thermal sensation were performed using a TSA II thermal sensory testing device (Medoc Inc, Israel), which has a 3 cm 2 contact area. Warm detection and heat pain thresholds (WDT and HPT, respectively) were investigated, and are thought to represent C-fiber function, with higher values representing lower functioning. 20 All thresholds were obtained using ramped stimuli (11C/s) that were terminated when the participant pressed a stop button. The cutoff temperature was 501C, and the baseline temperature was 321C.
Mechanical Testing
Mechanical detection threshold (MDT) was measured with a set of 7 von Frey filaments forming a geometric series, incrementing by a factor of 2 from 8 to 512 mN (University Hospital of Angers, France). The contact area of the von Frey hairs with the skin was of uniform size and shape (rounded tip, 0.5 mm in diameter) to avoid sharp edges that would facilitate nociceptor activation. Using the method of limits, 5 ascending and 5 descending series of stimuli were applied (1 s duration per stimulus). This test was used to assess the sensitivity of low threshold mechanoreceptors and myelinated Ab fibers, with higher values representing lower functioning. 21 Mechanical pain threshold (MPT) was measured in a similar manner to the former test using punctate mechanical stimulators (blunt pinpricks) the intensity of which again followed a geometric series, incrementing by a factor of 2 from 8 to 512 mN (University Hospital of Angers). The pinpricks had a sharp noninjuring tip with a diameter of 0.2 mm. The participants were asked to report whether they felt a prick or a blunt touch. The MPT is thought to represent Ad-fiber function, with higher values representing lower functioning. 22 Vibration detection threshold (VDT) was examined with a Rydel-Seiffer tuning fork (128 Hz, 8/8 scale) that was placed over a bony prominence (base knuckle of the middle phalanx, malleolus medialis). VDT was assessed with 3 series of descending stimulus intensities, and is thought to represent Ab-fiber function, with lower values representing higher functioning. 23 
Neuropathy Scores
The presence or absence of lower-limb neuropathy was tested in accordance with the recommendations of the American Diabetes Association and American Academy of Neurology 24 using the Neuropathy Symptom Score (NSS) and Neuropathy Disability Score (NDS). The NSS and NDS range 0 to 10 and 0 to 5, respectively. Scores are zero in the absence of neuropathy.
Data Analysis
For categorical variables, differences between groups were assessed using w 2 tests. For continuous variables, normality of distribution was first assessed using the Kolmogorov-Smirnov goodness-of-fit test. For normally distributed outcomes, differences between groups were assessed using Student t tests and differences between body regions were assessed using paired t tests. For non-normally distributed outcomes, differences between groups were assessed using Mann-Whitney U tests and differences between body regions were assessed using Wilcoxon signed-rank tests. Bivariate relationships were assessed using the Pearson product-moment correlation coefficient (r). Statistical analyses were performed using SPSS for Windows version 15.0. Statistical significance was set at Pr0.05 and data are expressed as mean ± SD, unless otherwise stated.
RESULTS
Patients and Controls
The characteristics of the 2 groups are shown in Table 1 . Sex, age, body mass, stature, body mass index, and resting blood pressure did not differ between the patients and controls (all P>0.05). Resting ankle-brachial pressure index was lower in patients than controls (P<0.01), although 12 of the 17 patients (71%) had normal values (>0.90). The latter is a logical result for IPI patients, as this situation generally results from lesions on the hypogastric branches of the arterial tree. There tended to be more smokers in the patient group compared with the control group (35 vs. 6%; P = 0.10). Medication usage was generally similar between groups (Table 1) , although a greater proportion of patients used calcium-channel blockers, antiplatelet agents and arterial vasodilators (all P<0.01).
Treadmill walking performance was 256 ± 219 m in patients whereas all controls completed the 965 m of the test (P<0.01). The TcpO 2 data showed that all patients had IPI, with average proximal and distal DROP scores of À27 ± 8 and À 10 ± 3, respectively. None of the controls had exercise-induced ischemia, and the average proximal and distal DROP scores were greater than those of the patients ( À6 ± 3 and À6 ± 2, respectively; P<0.01). 
Somatosensory Testing
Due to technical difficulties, we had 5 missing data points, all in the patient group, one in each of the following tests: leg WDT, arm MDT, leg and arm MPT, and leg VDT (ie, n = 16 for the patient group for each of these tests). The SST data are presented in Table 2 . Lower-limb WDT and VDT were increased (ie, more intense stimuli are needed) in patients compared with controls (P = 0.05 and 0.02, respectively). All other between-group comparisons were nonsignificant (P>0.05), although there was a trend toward an increased MDT in the lower limb of patients (P = 0.10). In the patient group, the detection thresholds for the WDT, MDT, MPT, and VDT tests were higher in the affected leg when compared with the arm (all P<0.05). In contrast, there were no significant arm-leg differences in the control group (all P>0.05). None of the SST variables were correlated with walking performance (all P>0.05).
Neuropathy Scores
The NSS and NDS tended to be higher in patients compared with controls (4.1 ± 3.4 vs. 2.6 ± 3.8, P = 0.09 and 1.3 ± 1.1 vs. 0.7 ± 1.1, P = 0.06, respectively). In the patient group, NSS was not correlated with any of the SST variables (all P>0.05). However, NDS was moderately correlated with lower-limb HPT (r = 0.50, P = 0.04), MDT (r = 0.48, P = 0.05), MPT (r = 0.50, P = 0.05), and VDT (r = À0.61, P = 0.02). Treadmill walking performance was negatively correlated with NDS (r = À0.49, P = 0.05), but it was not associated with NSS (r = À0.33, P = 0.20).
DISCUSSION
The purpose of this study was to compare somatosensory function between patients with IPI and age-matched and sex-matched healthy controls. The main finding was that lower-limb WDT and VDT were increased (more intense stimuli are needed) in patients compared with controls, which suggests abnormal functioning of C and Ab fibers, respectively. These abnormalities appear confined to the diseased lower limbs because upper-limb SST results did not differ between groups. The trends for an increased lower-limb MDT and higher NSS and NDS in the patients also support the association between IPI and lower-limb sensory impairment. Lower-limb sensory nerve dysfunction might contribute to the exercise-induced ischemic symptoms experienced in this form of moderate PAD.
Isolated proximal-without-distal claudication can result from atherosclerotic narrowing of the internal iliac artery, 25 as was the case for the patients in this study, or as a complication of aortoiliac surgery 26 or endovascular intervention. 27 Most cases of "atherosclerotic" proximal claudication presented in the literature are isolated observations, 25, [28] [29] [30] [31] [32] [33] suggesting that this form of PAD is relatively rare. In recent years, we have shown that combining proximal (buttock) and distal (calf) recordings of TcpO 2 during treadmill walking exercise provides the opportunity to objectively and simultaneously determine the presence of proximal and absence of distal regional blood flow impairment, respectively in each lower limb. 14, [16] [17] [18] [19] 34 Using this technique, we have reported the prevalence of IPI to be 5% to 14% in patients with mild-tomoderate PAD, 14, 19 and 28% in patients who had received aortobifemoral bypass surgery. 34 Therefore, IPI seems to be more common than is largely appreciated. The use of exercise TcpO 2 measurements in this study has allowed us to report one of the largest ever series of patients with IPI.
Our findings suggest that the functional integrity of small unmyelinated and myelinated sensory afferents (C and Ab fibers, respectively) is compromised in patients with IPI. This is consistent with the findings of Lang et al 2 who reported that WDT, MDT, and VDT are increased in patients with moderate PAD. However, a more recent study by this group 3 indicated that somatosensory function did not differ between nondiabetic claudicants and agematched healthy controls, except for a lower pain pressure threshold in patients, which might indicate the presence of hyperalgesia. The reasons for these discrepancies are unclear but might be partly due to the location of atherosclerotic disease varying between the participants of the earlier studies. Indeed, the location of atherosclerotic narrowing will determine which nerves/segments of nerves will become ischemic during exercise. We hypothesized that patients with isolated proximal claudication would have impaired lower-limb somatosensation because the blood supply of the sacral nerve plexus, which supplies sensory innervation to the legs, 11 derives predominantly from the branches of the internal iliac artery. 12 Furthermore, patients with internal iliac artery disease 13 or IPI 14 often experience burning, tingling, and numbness during exercise, which are common symptoms of small-fiber neuropathy. 15 The fact that the observed sensory disturbances were confined to the affected lower limbs suggests that they were caused by local factors, such as exercise-induced ischemia, rather than systemic ones, such as atherosclerotic inflammation or abnormal metabolic status. Indeed, the latter can probably be excluded because all participants were nondiabetic. Peripheral nerves on the one hand have a high tolerance to ischemia due to the double blood supply. 35, 36 On the other, the peripheral nerve has a significantly increased energy metabolism during activity 37 and a low capability of autoregulation of the blood supply. 38 Therefore, in patients with IPI, it can be assumed that perfusion to the sacral nerve plexus is sufficient at rest but not during exercise. Repeated bouts of exercise-induced ischemia to the sacral nerve region might result in acute neurological symptoms such as pain, paresthesia, and sensory and motor deficits, 13 as well as chronic impairments in sensory nerve function, as observed in this study.
Optimal therapy for patients with IPI likely involves the treatment of underlying vascular stenoses (if treatable) and the management of atherosclerotic risk factors; however, further research is needed to investigate the extent to which treatment can ameliorate symptoms and sensory nerve impairments in these patients. Lang et al 3 recently reported that sensory nerve function, as assessed using a comprehensive QST protocol, was unchanged up to 3 months after percutaneous transluminal angioplasty in 17 patients with intermittent claudication. Although suggestive of sensory impairments being insensitive to revascularization, this finding might be explained by the study being underpowered or the fact that sensory function scores did not differ markedly between patients and controls before intervention. Interestingly, patients were being treated for stenoses of the superficial femoral artery, which in perspective of the present findings, might suggest that the association between moderate exercise-induced ischemia and sensory nerve function is dependent on the location of atherosclerotic narrowing.
This study has several limitations. First, our sample size, albeit similar to that of earlier PAD studies, 2,3 was relatively small. This was largely due to the strict inclusion/ exclusion criteria limiting the number of eligible patients. Nevertheless, and as previously underlined, it represents a large series for IPI: a relatively rare clinical situation. The relatively small sample size might explain the curious finding that Ab and C fibers were impaired in the patients, whereas the intermediate Ad fibers (reflected by the MPT) were not. Given that the mean value of the MPT for the patients was double that of the controls (Table 2) , it seems reasonable to suggest that the between-group comparison for this test would have been statistically significant if more patients had been tested. Second, although our strict inclusion/exclusion criteria will have helped avoid other potential causes of sensory impairment (eg, diabetes), we cannot exclude the possibility that patients had subclinical metabolic dysfunction (ie, impaired glucose tolerance, impaired fasting glucose) or that the sensory disturbances were caused by something else that we did not control for (eg, systemic inflammation). Third, our inclusion/exclusion criteria might limit the generalization of our findings to other patients with IPI. However, in the "general" population of patients with IPI, where comorbidities such as diabetes are highly prevalent, it might be expected that sensory nerve function is more depressed compared with patients with IPI alone. Finally, we are unable to state if and how the sensory impairments of patients with IPI differ from those with other forms of exercise-induced ischemia (eg, isolated distal-without-proximal lower-limb exerciseinduced ischemia); further research is needed in this area.
In summary, we present a comparison of sensory nerve function, as assessed by SST, between patients with IPI and age-matched and sex-matched healthy controls. Lowerlimb WDT and VDT were in patients compared with healthy controls, suggesting abnormal functioning of C and Ab fibers, respectively. These sensory disturbances were most likely caused by transient exercise-induced ischemia to the sacral nerve plexus secondary to atherosclerotic lesions in the arteries supplying the pelvic region. Sensory neuropathy might contribute to the exercise-induced ischemic symptoms experienced in these patients.
This study may have important clinical implications. Claudication and walking limitation can result from various diseases, including PAD or lumbar spine stenosis. These 2 conditions share many similar symptoms, especially when PAD is in the form of IPI. The diagnosis of both lumbar spine stenosis and IPI remains challenging. Further research is needed to identify if sensory nerve function differs between these 2 situations. Until then, sensory testing might be of little use for identifying the underlying cause of proximal exercise-induced symptoms, because sensory disturbances might occur in both IPI and lumbar spine stenosis.
